person · Reporting owner
ZUCCONI THEODORE DANIEL
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GALECTIN THERAPEUTICS INCGALT · Entity 5577 | Director | April 16, 2018 | April 18, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GALECTIN THERAPEUTICS INC
Report date April 16, 2018 · Filed April 18, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,083 |
Ending reported balance
After 2018-04-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-04-16 · Exercise / conversion · Acquired 4,000 · Balance 5,083 Row 2 · 2018-04-16 · Sale · Disposed 4,000 · Balance 1,083 |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.89 · Expires 2026-12-15 | Direct | 27,250 |
Reported balance
After 2018-04-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-04-16 · Exercise / conversion · Disposed 4,000 · Balance 27,250 F1: The options vested 100% on the date of Galectin Therapeutics, Inc.'s 2017 Annual Stockholders Meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vested 100% on the date of Galectin Therapeutics, Inc.'s 2017 Annual Stockholders Meeting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 16, 2018 Filed Apr 18, 2018 20:31 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | Exercise / conversionStock option (right to buy) · Derivative | 4,000 | $0.00 Strike: $0.89 | $0.00 |
DisclosureSEC source: 0001179022-18-000026 · edgar.xml · derivative · entry 3 ZUCCONI THEODORE DANIEL · CIK 0001413699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,250 Underlying: Common stock · 4,000 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested 100% on the date of Galectin Therapeutics, Inc.'s 2017 Annual Stockholders Meeting. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:31 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | SaleCommon Stock | 4,000 | $3.58 | $14,320.00 |
DisclosureSEC source: 0001179022-18-000026 · edgar.xml · nonDerivative · entry 2 ZUCCONI THEODORE DANIEL · CIK 0001413699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,083 Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:31 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | Exercise / conversionCommon Stock | 4,000 | $0.89 | $3,560.00 |
DisclosureSEC source: 0001179022-18-000026 · edgar.xml · nonDerivative · entry 1 ZUCCONI THEODORE DANIEL · CIK 0001413699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 21:11 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | GrantStock option (right to buy) · Derivative | 46,875 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001179022-17-000077 · edgar.xml · derivative · entry 1 ZUCCONI THEODORE DANIEL · CIK 0001413699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,875 Underlying: Common stock · 46,875 shares Expires 2027-12-14 F1 · derivative.exercise_date: The options vest 100% on December 14, 2018. Read SEC document |
| May 23, 2017 Filed May 24, 2017 13:39 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | PurchaseCommon stock | 1,000 | $2.27 | $2,270.00 |
DisclosureSEC source: 0001179022-17-000029 · edgar.xml · nonDerivative · entry 1 ZUCCONI THEODORE DANIEL · CIK 0001413699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,083 Read SEC document |
| January 13, 2017 Filed Jan 20, 2017 21:46 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | SaleWarrants (right to buy) · Derivative | 85 | $0.35 Strike: $5.63 | $29.75 |
DisclosureSEC source: 0001179022-17-000001 · edgar.xml · derivative · entry 2 ZUCCONI THEODORE DANIEL · CIK 0001413699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38 Underlying: Common stock · 85 shares Expires 2017-03-28 Read SEC document |
| January 12, 2017 Filed Jan 20, 2017 21:46 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | SaleWarrants (right to buy) · Derivative | 2,299 | $0.48 Strike: $5.63 | $1,103.52 |
DisclosureSEC source: 0001179022-17-000001 · edgar.xml · derivative · entry 1 ZUCCONI THEODORE DANIEL · CIK 0001413699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123 Underlying: Common stock · 2,299 shares Expires 2017-03-28 Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:26 UTC | GALECTIN THERAPEUTICS INC GALT · Entity 5577 | GrantStock option (right to buy) · Derivative | 31,250 | $0.00 Strike: $0.89 | $0.00 |
DisclosureSEC source: 0001179022-16-000133 · edgar.xml · derivative · entry 1 ZUCCONI THEODORE DANIEL · CIK 0001413699 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common stock · 31,250 shares Expires 2026-12-15 F1 · derivative.exercise_date: The options vest 100% on the date of Galectin Therapeutics, Inc.'s 2017 Annual Stockholders Meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.